According to a market report by Lucintel, the future of the antipsychotic drug market in Germany looks promising with opportunities in the schizophrenia, dementia, bipolar disorder, and depression markets. The antipsychotic drug market in Germany is expected to reach an estimated $21 billion by 2031, with a CAGR of 5.8% from 2025 to 2031. The major drivers for this market are the rise in prevalence of mental disorders and growing awareness regarding mental health.
A more
than 150-page report to understand trends, opportunity and forecast in
antipsychotic drug market in Germany to 2031 by therapeutic class
(first-generation and second-generation), distribution channel (hospital
pharmacy, retail pharmacy, and online pharmacy), and application
(schizophrenia, dementia, bipolar disorder, depression, and others).
Download
sample by clicking on antipsychotic
drug market in Germany.
Lucintel
forecasts that, within the therapeutic class category, second-generation will
remain the larger segment over the forecast period.
Within the
application category, schizophrenia will remain the largest segment due to an
increase in incidences of schizophrenic disorders.
This unique research
report will enable you to make confident business decisions in this globally
competitive marketplace. For a detailed table of contents, contact Lucintel at
+1-972-636-5056 or write us at helpdesk@lucintel.com. To get access of more than 1000 reports at fraction of cost
visit Lucintel's Analytics
Dashboard.
About Lucintel
At Lucintel, we offer solutions for
you growth through game changer ideas and robust market &
unmet needs analysis. We are based in
Dallas, TX and have been a trusted advisor for 1,000+ clients for over 20
years. We are quoted in several publications like the Wall Street Journal,
ZACKS, and the Financial Times.
Contact:
Roy Almaguer
Lucintel
Dallas, Texas, USA
Email: roy.almaguer@lucintel.com
Tel. +1-972-636-5056
Explore Our Latest Publications
Antipsychotic Drug Market in Italy
Antipsychotic Drug Market in Netherlands
Antipsychotic Drug Market in Spain
No comments:
Post a Comment